| Literature DB >> 24607602 |
A M Batterham1, S Bonner2, J Wright2, S J Howell3, K Hugill2, G Danjoux4.
Abstract
BACKGROUND: Evidence is limited for the effectiveness of interventions for survivors of critical illness after hospital discharge. We explored the effect of an 8-week hospital-based exercise-training programme on physical fitness and quality-of-life.Entities:
Keywords: anaerobic threshold; cardiopulmonary exercise test; rehabilitation, exercise therapy
Mesh:
Year: 2014 PMID: 24607602 PMCID: PMC4062299 DOI: 10.1093/bja/aeu051
Source DB: PubMed Journal: Br J Anaesth ISSN: 0007-0912 Impact factor: 9.166
Sample baseline characteristics. Data are mean (sd) unless stated; the median and inter-quartile range (IQR) are presented for grossly skewed variables. APACHE, acute physiology and chronic health evaluation; ICNARC, Intensive Care National Audit and Research Centre; ICU, intensive care unit; LOS, length of stay; AT, anaerobic threshold; PF, physical function sub-scale; MH, mental health sub-scale; VAS, visual analogue scale; HADS, hospital anxiety and depression scale. For AT, n=21 control: 15 intervention. For peak oxygen uptake, HADS, EQ-5D, SF-36 PF, and timing of baseline measures post-discharge variables, n=25 control: 21 intervention. For SF-36 MH, n=25 control: 20 intervention. Additional details on specific reasons for ICU admission and comorbidities are provided in Supplementary Table S1
| Variable | Control ( | Intervention ( |
|---|---|---|
| Age in years [mean (range)] | 40.5 (19–60) | 42.7 (18–65) |
| Sex (number female/male) | 11/19 | 10/19 |
| Diagnosis (number with trauma/sepsis) | 13/17 | 15/14 |
| APACHE-II | 16.4 (7.8) | 15.9 (7.9) |
| ICNARC physiology score | 23.2 (9.5) | 18.4 (8.2) |
| ICU LOS (days) [median (IQR)] | 15 (7–23) | 15 (10–23) |
| Total hospital LOS (days) [median (IQR)] | 35 (26–50) | 45 (31–93) |
| Timing of baseline measures post-hospital discharge (weeks) | 11.1 (2.6) | 10.3 (1.9) |
| Number of ventilator days [median (IQR)] | 10 (5–19) | 12 (8–18) |
| AT (ml O2 kg−1 min−1) | 10.4 (2.8) | 10.4 (3.5) |
| SF-36 PF | 37.4 (13.1) | 36.7 (13.2) |
| SF-36 MH | 48.8 (11.6) | 43.0 (13.1) |
| SF-36 PF pre-morbid estimate | 50.0 (10.9) | 50.0 (12.2) |
| SF-36 MH pre-morbid estimate | 50.0 (12.1) | 48.7 (11.6) |
| Peak oxygen uptake (ml O2 kg−1 min−1) | 17.7 (6.9) | 17.8 (7.7) |
| EQ-5D index [median (IQR)] | 0.725 (0.516–0.814) | 0.689 (0.258–0.822) |
| EQ-5D VAS | 64 (23) | 61 (26) |
| HADS-Anxiety [median (IQR)] | 7.0 (2.5–11.0) | 7.0 (4.0–12.0) |
| HADS-Depression [median (IQR)] | 3.0 (1.0–7.5) | 5.0 (2.0–8.5) |
Fig 1The CONSORT participant flow diagram for primary endpoints.
Effects on primary outcomes adjusted for baseline value. The adjusted mean value for each group at each time point is shown, with the numbers analysed in parentheses. AT, anaerobic threshold; PF, physical function sub-scale; MH, mental health sub-scale. *Also adjusted for baseline SF-36 mental health
| Primary Outcome | Time point (week) | Control | Intervention | Difference (95% confidence interval) |
|---|---|---|---|---|
| AT (ml O2 kg−1 min−1) | 9 | 10.7 (17) | 12.5 (13) | 1.8 (0.4–3.2) |
| 26 | 12.1 (20) | 12.7 (18) | 0.6 (−1.6 to 2.8) | |
| SF-36 PF* | 9 | 40.1 (23) | 43.5 (18) | 3.4 (−1.4 to 8.2) |
| 26 | 46.6 (25) | 46.7 (21) | 0.1 (−6.0 to 6.2) | |
| SF-36 MH | 9 | 47.9 (23) | 49.8 (18) | 1.9 (−3.9 to 7.7) |
| 26 | 46.6 (25) | 51.0 (21) | 4.4 (−2.4 to 11.2) |
Effects on secondary outcomes adjusted for baseline value. The adjusted mean value for each group at each time point is shown, with the numbers analysed in parentheses. EQ-5D index, EuroQol-5D index (UK time trade-off value set); EQ-5D VAS, EuroQol-5D 100 mm visual analogue scale; HADS-Anxiety, Hospital Anxiety and Depression Scale Anxiety; HADS-Depression, Hospital Anxiety and Depression Scale Depression
| Outcome | Time point (weeks) | Control | Intervention | Difference (95% confidence interval) |
|---|---|---|---|---|
| Peak oxygen uptake (ml O2 kg−1 min−1) | 9 | 20.5 (21) | 21.1 (18) | 0.6 (−1.8 to 3.0) |
| 26 | 20.4 (23) | 22.0 (21) | 1.6 (−1.0 to 4.2) | |
| EQ-5D index | 9 | 0.684 (23) | 0.700 (18) | 0.016 (−0.104 to 0.137) |
| 26 | 0.712 (25) | 0.669 (21) | −0.043 (−0.174 to 0.088) | |
| EQ-5D VAS | 9 | 70.3 (22) | 70.1 (18) | −0.2 (−8.7 to 8.3) |
| 26 | 74.1 (24) | 70.0 (20) | −4.1 (−14.9 to 6.7) | |
| HADS-Anxiety | 9 | 6.6 (23) | 6.7 (18) | 0.1 (−1.6 to 1.8) |
| 26 | 7.0 (25) | 6.3 (21) | −0.7 (−2.9 to 1.5) | |
| HADS-Depression | 9 | 4.9 (23) | 4.1 (18) | −0.8 (−2.1 to 0.5) |
| 26 | 4.8 (25) | 4.0 (21) | −0.8 (−2.6 to 1.0) |